Anticholinergic therapy: do the patients take the pills prescribed?
Authors:
- 3 November 2010
- journal article
- general gynecology
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 284 (3) , 663-666
Abstract
Purpose To evaluate how many patients with overactive bladder still take their prescribed medication at least 12 months later and to find out the reasons for discontinuation of the therapy. Methods Two hundred and ten patients who had received a prescription for anticholinergic medication were contacted by telephone 12–46 months later. Results Out of 210 eligible patients 132 (63%) could be contacted and gave consent to participate in the study. 38% of them still took their medication after at least 12 months. 17% were continent or much improved, 13% a little improved, 8% were not improved, although still taking their medication. 62% did not take the original medication any more. 10% had never started with the medication, 42% took the medication for 3 months and 8% for 4–12 months. 25% had changed to another anticholinergic drug. Conclusion Anticholinergic therapy is often discontinued by patients and doctors. Patients with OAB therefore need counselling and follow-up in the long term to make sure that alternative treatment is offered if anticholinergic treatment does not work.Keywords
This publication has 13 references indexed in Scilit:
- Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract SymptomsObstetrics & Gynecology, 2008
- Survey Assessment of Continuation of and Satisfaction with Pharmacological Treatment for Urinary IncontinenceValue in Health, 2008
- Anticholinergic drugs versus other medications for overactive bladder syndrome in adultsCochrane Database of Systematic Reviews, 2007
- The Current and Future Burden and Cost of Overactive Bladder in Five European CountriesEuropean Urology, 2006
- Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladderWorld Journal of Urology, 2005
- Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid ProgramValue in Health, 2005
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladderBritish Journal of Urology, 1998
- A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder complianceBJOG: An International Journal of Obstetrics & Gynaecology, 1997